Not Yet Recruiting NA INTERVENTIONAL 2-arm
NCT07379502
Endometrial Response in Polycystic Ovarian Syndrome Treated With Letrozole Alone or With Added Estradiol Valerate
Endometrial Response in Women With Poorly Primed Endometrial Lining in Diagnosed Polycystic Ovarian Syndrome Treated With Letrozole Alone or With Added Estradiol Valerate
Sponsor: CMH Kharian Medical College
Conditions
PCOS (Polycystic Ovary Syndrome)
Interventions
Letrozole (Aromatase Inhibitors) Letrozole (Aromatase Inhibitors) + Estradiol valerate
Updated 1 time since 2026 Last updated: Jan 27, 2026 Started: Mar 5, 2026 Primary completion: Jun 30, 2026 Completion: Aug 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates PCOS (Polycystic Ovary Syndrome) and is currently actively recruiting participants. CMH Kharian Medical College leads this study, which shows 1 recorded version since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- CMH Kharian Medical College
Data source: CMH Kharian Medical College
For direct contact, visit the study record on ClinicalTrials.gov .